QCDx, Inc., a pioneering diagnostics company specializing in the detection and characterization of circulating tumor cells (CTCs), announced the successful closing of $7 million in new financing. The ...

Discover Biotium’s new RNaseReveal™ Activity Assay Kit—ultrasensitive RNase detection with a fast, easy protocol to ...

Creative Diagnostics has announced its highly validated antibodies for tRNA Modification Detection. NEW YORK, NY, UNITED STATES, April 28, 2025 /EINPresswire.com/ -- Creative Diagnostics, a leading ...

Growth in the Lateral Flow Assays market is propelled by increasing infectious disease incidences, rising demand for point-of-care testing, and advancements in home-based diagnostic kits. Key market ...